EGFR-targeting, β-defensin-tailored fusion protein exhibits high therapeutic efficacy against EGFR-expressed human carcinoma via mitochondria-mediated apoptosis

EGFR-targeting, β-defensin-tailored fusion protein exhibits high therapeutic efficacy against EGFR-expressed human carcinoma via mitochondria-mediated apoptosisEGFR-targeting, β-defensin-tailored fusion protein exhibits high therapeutic efficacy against EGFR-expressed human carcinoma via mitochondria-mediated apoptosis, Published online: 16 July 2018; doi:10.1038/s41401-018-0069-8EGFR-targeting, β-defensin-tailored fusion protein exhibits high therapeutic efficacy against EGFR-expressed human carcinoma via mitochondria-mediated apoptosis

Source: Acta Pharmacologica Sinica - July 16, 2018 Category: Drugs & Pharmacology Authors: Wen-Juan Liu Xiu-Jun Liu Jian Xu Liang Li Yi Li Sheng-Hua Zhang Jia-Lin Wang Qing-Fang Miao Yong-Su Zhen Source Type: research